Okada M, Kato K, Cho BC, Takahashi M, et al. Three-year follow-up and response-survival relationship of nivolumab in previously treated patients with advanced esophageal squamous cell carcinoma (ATTRACTION-3). Clin Cancer Res 2022 Mar 16. pii: 682194. doi: 10.1158/1078-0432.CCR-21-0985.
PMID: 35294546